Showing results (41-50 of 62) with videos related to
Sort By:
Pageof 7
Scandinavian Journal of Immunology|June 1, 1987
Expression of CR1 and CR2 complement receptors following Epstein-Barr virus infection of Burkitt's lymphoma cell linesJ H Cohen, E Fischer, M D Kazatchkine, et al.Journal of Immunology (Baltimore, Md. : 1950)|October 1, 1985
Human follicular dendritic cells express CR1, CR2, and CR3 complement receptor antigensM Reynes, J P Aubert, J H Cohen, et al.American Journal of Ophthalmology|January 15, 1992
HLA-A29.2 subtype associated with birdshot retinochoroidopathyP LeHoang, N Ozdemir, A Benhamou, et al.Transplantation|November 27, 1996
False-negative results in anti-HLA antibody detection by Sangstat ELISA: complement dependent cytotoxicity is not yet obsoleteA Pierquin, D Masson, O Toupance, et al.Journal of Immunological Methods|May 4, 1987
Enumeration of CR1 complement receptors on erythrocytes using a new method for detecting low density cell surface antigens by flow cytometryJ H Cohen, J P Aubry, M H Jouvin, et al.Proceedings of the National Academy of Sciences of the United States of America|April 16, 1996
Definition of the HLA-A29 peptide ligand motif allows prediction of potential T-cell epitopes from the retinal soluble antigen, a candidate autoantigen in birdshot retinopathyF Boisgerault, I Khalil, V Tieng, et al.Clinical and Experimental Immunology|December 14, 1999
Effect of plasmapheresis on ligand binding capacity and expression of erythrocyte complement receptor type 1 (CR1) of patients with systemic lupus erythematosus (SLE)I Csípö, E Kiss, P Soltész, et al.Revue Du Rhumatisme Et Des Maladies Osteo-Articulaires|January 1, 1983
[Strict correlation between anti-RANA antibodies and anti-EBNA antibodies apart from rheumatoid arthritis. Assessment of the diagnostic value of anti-RANA antibody]J H Cohen, G M Lenoir, J F Colmet-Daage, et al.Immunopharmacology|February 26, 1998
Catabolism of the human erythrocyte C3b/C4b receptor (CR1, CD35): vesiculation and/or proteolysis?X Dervillez, S Oudin, M T Libyh, et al.Journal of Virology|April 25, 2000
Octamerization enables soluble CD46 receptor to neutralize measles virus in vitro and in vivoD Christiansen, P Devaux, B Réveil, et al.Pageof 7